Literature DB >> 21513449

Early surgical treatment protocol for sciatic nerve injury due to injection--a retrospective study.

Kivanç Topuz1, Murat Kutlay, Hakan Simşek, Cem Atabey, Mehmet Demircan, Mehmet Senol Güney.   

Abstract

BACKGROUND AND
PURPOSE: We retrospectively researched 119 patients with buttock level traumatic injury to sciatic nerves and 42 cases of sciatic nerve injuries due to intramuscular injections were observed among them. Our aim was finding out the post-operative outcomes of early intervention and describing a timing schedule for surgical intervention.
METHODS: Between 1984 and 2004 a total of 73 patients were operated on to explore the nerve lesion. These injuries consisted of post-injection injury, hip fracture/dislocation, contusion, compression, gunshot wound, hip arthroplasty and laceration. Our study took into account 29 cases operated because of injection injury. The most common presenting symptom was pain, which often masked underlying loss of function. Findings at operation were analysed according to the type of sciatic nerve damaged following intramuscular injection, the nature of this injury and the referring speciality. Some of the more common causal operations and procedures are discussed. Preventive measures are listed, and early diagnosis and treatment are recommended. The aim of the operation was to establish the diagnosis, to resolve pain and to improve function by epineural or interfasciculary neurolysis.
RESULTS: We analysed the findings at operation according to the nature of the injury and the procedures which the patients underwent. Seven patients (24.1%) had an excellent outcome, 14 patients (48.2%) had good outcome and 4 patients (13.8%) had fair outcome. The other four patients (13.8%) had poor outcome. No patients suffered from additional post-operative neurological deficits or from worsening of pre-operative deficits.
CONCLUSIONS: Based on our experiences, we recommend measures by which the morbidity rate of these injuries may be reduced. We stress, however, that if the clinical evidence points to transection of a nerve, that nerve may be explored without waiting for electrophysiological confirmation. Delay in recognition and therefore treatment was a cause of litigation, and contributed to the poor outcome in many cases.

Entities:  

Mesh:

Year:  2011        PMID: 21513449     DOI: 10.3109/02688697.2011.566380

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  6 in total

Review 1.  Iatrogenic nerve injuries: prevalence, diagnosis and treatment.

Authors:  Gregor Antoniadis; Thomas Kretschmer; Maria Teresa Pedro; Ralph W König; Christian P G Heinen; Hans-Peter Richter
Journal:  Dtsch Arztebl Int       Date:  2014-04-18       Impact factor: 5.594

2.  Postoperative Deep Gluteal Syndrome After Hip Arthroscopic Surgery.

Authors:  Soshi Uchida; Kazuha Kizaki; Fumitaka Hirano; Hal David Martin; Akinori Sakai
Journal:  Orthop J Sports Med       Date:  2020-09-28

3.  Sciatic nerve compression by neurogenic heterotopic ossification: use of CT to determine surgical indications.

Authors:  Marjorie Salga; Claire Jourdan; Marie-Christine Durand; Chloé Hangard; Philippe Denormandie; Robert-Yves Carlier; François Genêt
Journal:  Skeletal Radiol       Date:  2014-09-14       Impact factor: 2.199

4.  Sciatica in the young.

Authors:  Sim Sai Tin; Viroj Wiwanitkit
Journal:  Asian Spine J       Date:  2014-10-18

5.  Effect of electroacupuncture on the expression of agrin and acetylcholine receptor subtypes in rats with tibialis anterior muscular atrophy induced by sciatic nerve injection injury.

Authors:  Jianqi Yu; Meng Wang; Junying Liu; Xiaoming Zhang; Shengbo Yang
Journal:  Acupunct Med       Date:  2017-01-09       Impact factor: 2.267

6.  Epidemiology and treatment outcomes in pediatric patients with post-injection paralysis.

Authors:  Siyou Song; Moses Fisha Muhumuza; Norgrove Penny; Coleen S Sabatini
Journal:  BMC Musculoskelet Disord       Date:  2022-08-05       Impact factor: 2.562

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.